Melanoma & Skin Cancer | Specialty

The OncLive Melanoma & Skin Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of skin cancers, including melanoma, basal cell carcinoma, and more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in melanoma and other skin cancers.

Dr. Freeman on Challenges in Treatment Selection in Melanoma

February 14th 2017

Morganna Freeman, DO, associate director, Melanoma and Cutaneous Oncology Program, The Angeles Clinic and Research Institute, discusses the challenges associated with treatment selection in melanoma.

Dr. Weber on Combination Strategies for BRAF-Mutant Melanoma

February 14th 2017

Jeffery S. Weber, MD, PhD, deputy director of the Laura and Isaac Perlmutter Cancer Center, co-director of the Melanoma Program, and head of Experimental Therapeutics at NYU Langone Medical Center, discusses combination strategies for patients with BRAF-mutant melanoma.

Dr. Gangadhar on Combination Regimens for Melanoma

February 14th 2017

Tara C. Mitchell, MD, assistant professor of Medicine, Perelman School of Medicine at the Hospital of the University of Pennsylvania, discusses new combination regimens for patients with melanoma.

Dr. Postow on Immunotherapy Advancements in Melanoma

February 13th 2017

Michael A. Postow, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses some of the advancements that have recently taken place in immunotherapy in the field of melanoma.

Dr. Hamid on Melanoma as a Therapeutic Driver for Other Cancers

February 12th 2017

Omid A. Hamid, MD, chief, Translational Research and Immunotherapy, director, Melanoma Therapeutics, The Angeles Clinic and Research Institute, discusses melanoma as a therapeutic driver for other tumor types during the 13th Annual 13th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® in Sunny Isles Beach, Florida.

Less Common Side Effects With Immunotherapy in Melanoma

February 8th 2017

Immunotherapy in Melanoma: Recognizing an Endocrinopathy

February 8th 2017

Melanoma: Testing for Immunotherapy-Related Hepatotoxicity

February 8th 2017

Immunotherapy-Related Pulmonary Toxicities in Melanoma

February 8th 2017

Managing Gastrointestinal Toxicities in Melanoma

February 8th 2017

Melanoma: Management of Dermatologic Toxicities

February 8th 2017

Overall Toxicities With Immunotherapy in Melanoma

February 8th 2017

Monotherapy Versus Combination Therapy Approaches in Melanoma

February 8th 2017

Melanoma: Speed and Durability of Therapeutic Response

February 8th 2017

BRAF-Mutant Melanoma: Frontline Decisions

February 8th 2017

Immunotherapy in BRAF Wild-Type Melanoma

February 8th 2017

Initial Treatment Approach in Advanced Melanoma: Factors to Consider

February 8th 2017

Explaining Therapeutic Options to Patients With Advanced Melanoma

February 8th 2017

Multidisciplinary Care for Advanced Melanoma at Georgetown University

February 8th 2017

Team Approach to Advanced Melanoma Treatment at MSKCC

February 8th 2017